What is the recommended frequency for self‑collected vaginal HPV (and STI) testing for a patient at the facility, and how should the test be ordered in the electronic health record?

Self-Collected Vaginal HPV Testing: Frequency and Ordering

For self-collected vaginal HPV testing, screen every 3 years for average-risk patients aged 25-65 years, compared to every 5 years when using clinician-collected cervical specimens. 1, 2

Screening Frequency Based on Collection Method

The critical distinction in screening intervals depends on how the specimen is collected:

Self-Collected Vaginal Specimens

• Every 3 years for HPV-negative results 1, 2
• This applies to FDA-approved combinations of collection devices and HPV assays used in clinical settings or at home
• The shorter interval accounts for slightly lower sensitivity compared to clinician-collected samples

Clinician-Collected Cervical Specimens (for comparison)

• Every 5 years for primary HPV testing (preferred) 3, 1
• Every 5 years for co-testing (HPV + cytology) (acceptable)
• Every 3 years for cytology alone (acceptable where primary HPV unavailable)

Age-Specific Recommendations

Ages 25-65 years:

• Self-collection is acceptable for average-risk individuals 1, 2
• Clinician-collected specimens remain preferred 2
• Begin screening at age 25 (not 21) 3

Age >65 years:

• To exit screening, require negative primary HPV tests at ages 60 AND 65 years 1
• If using self-collected specimens, follow the 3-year interval leading up to exit
• Must have no history of CIN2+ within past 25 years

Ordering in the Electronic Health Record

While specific facility ordering protocols vary, the order should specify:

1. Test type: "Primary HPV testing - self-collected vaginal specimen"
2. FDA-approved device/assay combination (facility-dependent)
3. Collection location: In-clinic vs. at-home (both acceptable) 2, 4
4. Follow-up interval: Document 3-year return for next screening if negative

Critical Follow-Up Pathways After Positive Results

HPV 16 or 18 positive:

• Immediate colposcopy with cytology and biopsies 2

Other high-risk HPV types positive (45,33/58,31,52,35/39/68,51, or pooled other types):

• Triage with clinician-collected cytology or dual stain (p16/Ki-67) 2
• Cannot use self-collected specimens for triage

HPV 56/59/66 positive only (no other carcinogenic types):

• Repeat HPV testing in 1 year 2

Important Caveats and Limitations

Self-collection is NOT appropriate for:

• Individuals with prior CIN2+ or cervical cancer 2
• Immunocompromised patients (HIV+, transplant recipients, chronic immunosuppression) 5, 2
• Surveillance after abnormal results or treatment (clinician-collected preferred) 2
• In utero DES exposure 5

Common pitfalls to avoid:

• Do not use the 5-year interval for self-collected specimens—this only applies to clinician-collected samples 1, 2
• Most HPV-positive patients require additional follow-up steps with clinician involvement 1
• Self-collected specimens cannot be used for cytology or dual stain triage testing 2
• Ensure only FDA-approved device/assay combinations are used 1

Practical implementation considerations:

• In-clinic self-collection shows higher agreement with clinician samples than at-home collection (particularly for HPV 18) 6
• Uptake rates are excellent (>90%) when integrated into routine care 4
• "Dry" swab storage at room temperature for up to 2 weeks maintains adequate DNA quality 7
• Laboratory and clinical workflows require modification for specimen processing and follow-up 2

The 3-year interval for self-collected specimens represents a balance between expanding access to screening (particularly for underscreened populations) and maintaining adequate sensitivity for detecting high-grade lesions, given the slightly lower performance compared to clinician-collected samples 1, 2.